Ocular Surface Disease Treatments in the Pipeline

• by Bela Parekh, MD, Jai G. Parekh, MD, MBA, FAAO

• May 1, 2025

Assessment of the aggregate index of systemic inflammation in dyslipidemia with dry eye disease: a retrospective case-control

• by Amani Y. Alhalwani, Asma Altasan, Nawaf Alasmari, Asma Almutiri, Mustafa Sunbul, Razan Khalifa, Jumanah Makhtoum, Shatha Jambi

• June 11, 2026

Dual Light Therapy Device for Dry Eye and OSD Management

Essilor Instruments' eye-light® delivers targeted, condition-specific management for ocular surface diseases

• June 2, 2026

• 2 min

Wogonoside alleviates hyperosmotic stress-induced inflammation and apoptosis in human corneal epithelial cells via PI3K/AKT signaling

• by Yuan Zhong, Jian Shi, Xi Long, Xiyuan Liu, Lihao Chen, Jun Peng, Qinghua Peng

• May 4, 2026